Recently, a study of immune inflammation in 105 BPH specimens revealed that the group with strong immune inflammation had larger prostate volumes, higher AR expression levels and higher serum prostate-specific antigen (PSA) levels (Wu et al., 2012[14]). This evidence concerns the gene AR and benign prostatic hyperplasia.